Literature DB >> 22075751

The effect of CYP7A1 polymorphisms on lipid responses to fenofibrate.

Jian Shen1, Donna K Arnett, Laurence D Parnell, Chao-Qiang Lai, Robert J Straka, Paul N Hopkins, Ping An, Mary F Feitosa, José M Ordovás.   

Abstract

INTRODUCTION: CYP7A1 encodes cholesterol 7α-hydroxylase, an enzyme crucial to cholesterol homeostasis. Its transcriptional activity is downregulated by fenofibrate. The goal of this study was to determine the effect of CYP7A1 polymorphisms on lipid changes in response to fenofibrate.
METHODS: We examined the associations of 3 tagging single nuclear polymorphisms (i6782C>T, m204T>G, 3U12536A>C) at CYP7A1 with triglyceride (TG) and high-density lipoprotein cholesterol (HDL)-C responses to a 3-week treatment with 160 mg/d of fenofibrate in 864 US white participants from the Genetics of Lipid Lowering Drugs and Diet Network study.
RESULTS: The m204T>G variant was significantly associated with TG and HDL-C responses with fenofibrate. Individuals homozygous for the common T allele of m204T>G single nuclear polymorphism displayed both the greater reduction of TG (-32% for TT, -28% for GT, -25% for GG, P = 0.004) and an increase of HDL-C response compared with noncarriers (4.1% for TT, 3.4% for GT, 1.2% for GG, P = 0.01). Conversely, individuals homozygous for the minor allele of i6782C>T showed a greater increase in the HDL-C response compared with noncarriers (2.8% CC, 4.5% for CT, 5.8% for TT, P = 0.02), albeit no significant effect on TG response.
CONCLUSIONS: Our data suggest that common variants at the CYP7A1 locus modulate the TG-lowering and HDL-C-raising effects of fenofibrate, and contribute to the interindividual variation of the drug responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22075751      PMCID: PMC3868459          DOI: 10.1097/FJC.0b013e31823de86b

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  37 in total

Review 1.  Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy.

Authors:  James D Otvos
Journal:  Clin Lab       Date:  2002       Impact factor: 1.138

Review 2.  Bile acid biosynthesis.

Authors:  D W Russell; K D Setchell
Journal:  Biochemistry       Date:  1992-05-26       Impact factor: 3.162

3.  NHLBI Family Heart Study: objectives and design.

Authors:  M Higgins; M Province; G Heiss; J Eckfeldt; R C Ellison; A R Folsom; D C Rao; J M Sprafka; R Williams
Journal:  Am J Epidemiol       Date:  1996-06-15       Impact factor: 4.897

4.  Complex genetic control of HDL levels in mice in response to an atherogenic diet. Coordinate regulation of HDL levels and bile acid metabolism.

Authors:  D Machleder; B Ivandic; C Welch; L Castellani; K Reue; A J Lusis
Journal:  J Clin Invest       Date:  1997-03-15       Impact factor: 14.808

5.  CYP7A1 A-278C polymorphism affects the response of plasma lipids after dietary cholesterol or cafestol interventions in humans.

Authors:  Maaike K Hofman; Rianne M Weggemans; Peter L Zock; Evert G Schouten; Martijn B Katan; Hans M G Princen
Journal:  J Nutr       Date:  2004-09       Impact factor: 4.798

6.  Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c.

Authors:  Mitsuhiro Watanabe; Sander M Houten; Li Wang; Antonio Moschetta; David J Mangelsdorf; Richard A Heyman; David D Moore; Johan Auwerx
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

7.  Effect of aging on cholesterol 7 alpha-hydroxylation in humans.

Authors:  M Bertolotti; N Abate; S Bertolotti; P Loria; M Concari; R Messora; F Carubbi; A Pinetti; N Carulli
Journal:  J Lipid Res       Date:  1993-06       Impact factor: 5.922

8.  Bile acid kinetics in relation to endogenous tryglyceride metabolism in various types of hyperlipoproteinemia.

Authors:  B Angelin; K Einarsson; K Hellström; B Leijd
Journal:  J Lipid Res       Date:  1978-11       Impact factor: 5.922

9.  Cholesterol 7alpha-hydroxylase deficiency in mice on an APOE*3-Leiden background impairs very-low-density lipoprotein production.

Authors:  Sabine M Post; Martine Groenendijk; Karianne Solaas; Patrick C N Rensen; Hans M G Princen
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-02-12       Impact factor: 8.311

10.  Diminished hepatic response to fasting/refeeding and liver X receptor agonists in mice with selective deficiency of sterol regulatory element-binding protein-1c.

Authors:  Guosheng Liang; Jian Yang; Jay D Horton; Robert E Hammer; Joseph L Goldstein; Michael S Brown
Journal:  J Biol Chem       Date:  2002-01-08       Impact factor: 5.157

View more
  10 in total

1.  Fibrate pharmacogenomics: expanding past the genome.

Authors:  John S House; Alison A Motsinger-Reif
Journal:  Pharmacogenomics       Date:  2020-03-17       Impact factor: 2.533

2.  Beneficial Effect of Fenofibrate and Silymarin on Hepatic Steatosis and Gene Expression of Lipogenic and Cytochrome P450 Enzymes in Non-Obese Hereditary Hypertriglyceridemic Rats.

Authors:  Rostislav Vecera; Martin Poruba; Martina Hüttl; Hana Malinska; Olena Oliyarnyk; Irena Markova; Zuzana Racova; Jan Soukop; Ludmila Kazdova
Journal:  Curr Issues Mol Biol       Date:  2022-04-26       Impact factor: 2.976

Review 3.  Pharmacogenomics of high-density lipoprotein-cholesterol-raising therapies.

Authors:  Stella Aslibekyan; Robert J Straka; Marguerite R Irvin; Steven A Claas; Donna K Arnett
Journal:  Expert Rev Cardiovasc Ther       Date:  2013-03

Review 4.  Quantile-Dependent Expressivity and Gene-Lifestyle Interactions Involving High-Density Lipoprotein Cholesterol.

Authors:  Paul T Williams
Journal:  Lifestyle Genom       Date:  2020-12-09

5.  Relationship between CYP7A1 -204A>C polymorphism with gallbladder stone disease and serum lipid levels: a meta-analysis.

Authors:  Qiang Cai; Zhen-Qiang Wang; Qu Cai; Chen Li; Er-Zhen Chen; Zhao-Yan Jiang
Journal:  Lipids Health Dis       Date:  2014-08-08       Impact factor: 3.876

6.  CYP7A1 gene polymorphism located in the 5' upstream region modifies the risk of coronary artery disease.

Authors:  Tomasz Iwanicki; Anna Balcerzyk; Pawel Niemiec; Tomasz Nowak; Anna Ochalska-Tyka; Jolanta Krauze; Sylwia Kosiorz-Gorczynska; Wladyslaw Grzeszczak; Iwona Zak
Journal:  Dis Markers       Date:  2015-04-06       Impact factor: 3.434

7.  Potential Mechanism of Action of Cyclosporin A in Human Dermal Fibroblasts-Transcriptomic Analysis of CYPs.

Authors:  Grażyna Janikowska; Alina Pyka-Pająk; Tomasz Janikowski; Jolanta Adamska; Urszula Mazurek; Przemysław Jędrusik
Journal:  Molecules       Date:  2018-07-05       Impact factor: 4.411

8.  Lipopolysaccharide-Induced Transcriptional Changes in LBP-Deficient Rat and Its Possible Implications for Liver Dysregulation during Sepsis.

Authors:  Zhixiang He; Zichen Song; Leilei Meng; Wenhui Cheng; Fan Huang; Mao Zheng; Wenhui Xu; Rong Xiao; Haoshu Fang; Yaling Zhu
Journal:  J Immunol Res       Date:  2021-12-30       Impact factor: 4.818

9.  Variants identified in a GWAS meta-analysis for blood lipids are associated with the lipid response to fenofibrate.

Authors:  Stella Aslibekyan; Mark O Goodarzi; Alexis C Frazier-Wood; Xiaofei Yan; Marguerite R Irvin; Eric Kim; Hemant K Tiwari; Xiuqing Guo; Robert J Straka; Kent D Taylor; Michael Y Tsai; Paul N Hopkins; Stanley G Korenman; Ingrid B Borecki; Yii-Der I Chen; Jose M Ordovas; Jerome I Rotter; Donna K Arnett
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  MiRNA-17 encoded by the miR-17-92 cluster increases the potential for steatosis in hepatoma cells by targeting CYP7A1.

Authors:  Ruijie Gong; Xiaofei Lv; Fengqiong Liu
Journal:  Cell Mol Biol Lett       Date:  2018-04-18       Impact factor: 5.787

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.